32374203|t|Impact of differential and time-dependent autophagy activation on therapeutic efficacy in a model of Huntington disease.
32374203|a|Activation of macroautophagy/autophagy, a key mechanism involved in the degradation and removal of aggregated proteins, can successfully reverse Huntington disease phenotypes in various model systems. How neuronal autophagy impairments need to be considered in Huntington disease progression to achieve a therapeutic effect is currently not known. In this study, we used a mouse model of HTT (huntingtin) protein aggregation to investigate how different methods and timing of autophagy activation influence the efficacy of autophagy-activating treatment in vivo. We found that overexpression of human TFEB, a master regulator of autophagy, did not decrease mutant HTT aggregation. On the other hand, Becn1 overexpression, an autophagic regulator that plays a key role in autophagosome formation, partially cleared mutant HTT aggregates and restored neuronal pathology, but only when administered early in the disease progression. When Becn1 was administered at a later stage, when prominent mutant HTT accumulation and autophagy impairments have occurred, Becn1 overexpression did not rescue the mutant HTT-associated phenotypes. Together, these results demonstrate that the targets used to activate autophagy, as well as the timing of autophagy activation, are crucial for achieving efficient therapeutic effects.Abbreviations: AAV: adeno-associated viral vectors; ACTB: actin beta; BECN1: beclin 1, autophagy related; DAPI: 4',6-diamidino-2-phenylindole; GO: gene ontology; HD: Huntington disease; HTT: huntingtin; ICQ: Li's intensity correlation quotient; IHC: immunohistochemistry; LAMP1: lysosomal-associated membrane protein 1; MAP1LC3B/LC3B: microtubule-associated protein 1 light chain 3 beta; mHTT: mutant huntingtin; PCA: principal component analysis; PPP1R1B/DARPP-32: protein phosphatase 1 regulatory inhibitor subunit 1B; SQSTM1: sequestosome 1; TFEB: transcription factor EB; WB: western blot; WT: wild-type.
32374203	101	119	Huntington disease	Disease	MESH:D006816
32374203	266	284	Huntington disease	Disease	MESH:D006816
32374203	382	400	Huntington disease	Disease	MESH:D006816
32374203	494	499	mouse	Species	10090
32374203	509	512	HTT	Gene	15194
32374203	514	524	huntingtin	Gene	15194
32374203	716	721	human	Species	9606
32374203	722	726	TFEB	Gene	7942
32374203	785	788	HTT	Gene	15194
32374203	821	826	Becn1	Gene	8678
32374203	942	945	HTT	Gene	15194
32374203	1056	1061	Becn1	Gene	56208
32374203	1119	1122	HTT	Gene	15194
32374203	1177	1182	Becn1	Gene	8678
32374203	1224	1227	HTT	Gene	15194
32374203	1487	1491	ACTB	Gene	11461
32374203	1493	1503	actin beta	Gene	11461
32374203	1505	1510	BECN1	Gene	56208
32374203	1512	1520	beclin 1	Gene	56208
32374203	1541	1545	DAPI	Chemical	MESH:C007293
32374203	1547	1576	4',6-diamidino-2-phenylindole	Chemical	MESH:C007293
32374203	1597	1599	HD	Disease	MESH:D006816
32374203	1601	1619	Huntington disease	Disease	MESH:D006816
32374203	1621	1624	HTT	Gene	15194
32374203	1626	1636	huntingtin	Gene	15194
32374203	1707	1712	LAMP1	Gene	16783
32374203	1714	1753	lysosomal-associated membrane protein 1	Gene	16783
32374203	1755	1763	MAP1LC3B	Gene	67443
32374203	1764	1768	LC3B	Gene	67443
32374203	1770	1821	microtubule-associated protein 1 light chain 3 beta	Gene	67443
32374203	1836	1846	huntingtin	Gene	15194
32374203	1883	1890	PPP1R1B	Gene	19049
32374203	1891	1899	DARPP-32	Gene	19049
32374203	1901	1954	protein phosphatase 1 regulatory inhibitor subunit 1B	Gene	19049
32374203	1956	1962	SQSTM1	Gene	18412
32374203	1964	1978	sequestosome 1	Gene	18412
32374203	1980	1984	TFEB	Gene	21425
32374203	1986	2009	transcription factor EB	Gene	21425
32374203	Association	MESH:D006816	15194

